ProtoKinetix, Inc.

ProtoKinetix, Inc. is a research and development stage biotechnology company that focuses on scientific medical research of Anti-Freeze Glycoproteins (AFGPs), which are trademarked as AAGPs®. These are also referred to as anti-aging glycoproteins. The company is currently directing significant efforts towards the commercial validation of AAGPs®. ProtoKinetix identifies numerous commercial applications for AAGPs® in large markets, particularly in targeted healthcare solutions. The company is actively collaborating with researchers, business leaders, advisors, and commercial entities to bring AAGP® to market. ProtoKinetix was originally incorporated as RJV Network, Inc. on December 23, 1999, in Nevada, with an initial focus on developing an internet-based listing site for commercial real estate. In July 2003, the company acquired rights to proprietary technologies from BioKinetix Research, Incorporated for the creation and commercialization of "superantibodies" through an assignment of license agreement. On July 8, 2003, the company changed its name to ProtoKinetix, Incorporated. The company's executive offices are located at 109 W Main St, Dalton, Ohio 44618.